y Agis Pharmaceuticals Inc., of Houston, received a U.S. patent, No.5,302,706, for the company's Sdi1 (Senescent Derived Inhibitor ofDNA Synthesis) technology. The patent covers claims to the Sdi1 geneand its antisense sequences. The gene was discovered at Baylor Collegeof Medicine in 1991, and licensed to Agis in July 1993.y Pharmos Corp., of New York, filed a U.S. patent application for anew analog of tamoxifen, a drug used to treat breast cancer. Thetamoxifen analog demonstrates at least equivalent cytotoxic activity inreference breast cancer animal models, without unwanted side effects,the company said.y Carrington Laboratories Inc., of Irving, Texas, received a U.S. patent,No. 5,284,833, which contains 50 claims pertaining to the company'swound cleanser line.
(c) 1997 American Health Consultants. All rights reserved.